DANAHER CORP (DHR) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:DHR • US2358511028

215.75 USD
-3.78 (-1.72%)
At close: Feb 5, 2026
216.9 USD
+1.15 (+0.53%)
After Hours: 2/5/2026, 8:20:24 PM
Fundamental Rating

6

Overall DHR gets a fundamental rating of 6 out of 10. We evaluated DHR against 57 industry peers in the Life Sciences Tools & Services industry. DHR scores excellent on profitability, but there are some minor concerns on its financial health. DHR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year DHR was profitable.
  • DHR had a positive operating cash flow in the past year.
  • DHR had positive earnings in each of the past 5 years.
  • Each year in the past 5 years DHR had a positive operating cash flow.
DHR Yearly Net Income VS EBIT VS OCF VS FCFDHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1.2 Ratios

  • DHR has a Return On Assets of 4.33%. This is in the better half of the industry: DHR outperforms 77.19% of its industry peers.
  • DHR has a Return On Equity of 6.88%. This is in the better half of the industry: DHR outperforms 77.19% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.19%, DHR is in the better half of the industry, outperforming 71.93% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DHR is significantly below the industry average of 13.80%.
Industry RankSector Rank
ROA 4.33%
ROE 6.88%
ROIC 5.19%
ROA(3y)4.99%
ROA(5y)6.19%
ROE(3y)7.87%
ROE(5y)10.34%
ROIC(3y)5.75%
ROIC(5y)6.56%
DHR Yearly ROA, ROE, ROICDHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

1.3 Margins

  • With an excellent Profit Margin value of 14.71%, DHR belongs to the best of the industry, outperforming 82.46% of the companies in the same industry.
  • DHR's Profit Margin has been stable in the last couple of years.
  • DHR has a better Operating Margin (19.15%) than 84.21% of its industry peers.
  • DHR's Operating Margin has been stable in the last couple of years.
  • DHR's Gross Margin of 59.17% is fine compared to the rest of the industry. DHR outperforms 77.19% of its industry peers.
  • In the last couple of years the Gross Margin of DHR has remained more or less at the same level.
Industry RankSector Rank
OM 19.15%
PM (TTM) 14.71%
GM 59.17%
OM growth 3Y-12.28%
OM growth 5Y0.11%
PM growth 3Y-17.98%
PM growth 5Y-1.36%
GM growth 3Y-0.91%
GM growth 5Y1.09%
DHR Yearly Profit, Operating, Gross MarginsDHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DHR is destroying value.
  • Compared to 1 year ago, DHR has less shares outstanding
  • Compared to 5 years ago, DHR has less shares outstanding
  • DHR has a worse debt/assets ratio than last year.
DHR Yearly Shares OutstandingDHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
DHR Yearly Total Debt VS Total AssetsDHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • DHR has an Altman-Z score of 4.36. This indicates that DHR is financially healthy and has little risk of bankruptcy at the moment.
  • DHR's Altman-Z score of 4.36 is fine compared to the rest of the industry. DHR outperforms 78.95% of its industry peers.
  • DHR has a debt to FCF ratio of 3.50. This is a good value and a sign of high solvency as DHR would need 3.50 years to pay back of all of its debts.
  • DHR has a Debt to FCF ratio of 3.50. This is amongst the best in the industry. DHR outperforms 80.70% of its industry peers.
  • A Debt/Equity ratio of 0.35 indicates that DHR is not too dependend on debt financing.
  • DHR has a Debt to Equity ratio of 0.35. This is comparable to the rest of the industry: DHR outperforms 47.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.5
Altman-Z 4.36
ROIC/WACC0.47
WACC10.94%
DHR Yearly LT Debt VS Equity VS FCFDHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.87 indicates that DHR should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.87, DHR is doing worse than 63.16% of the companies in the same industry.
  • DHR has a Quick Ratio of 1.51. This is a normal value and indicates that DHR is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.51, DHR is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.51
DHR Yearly Current Assets VS Current LiabilitesDHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

  • DHR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.14%.
  • DHR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.40% yearly.
  • The Revenue has been growing slightly by 2.90% in the past year.
  • The Revenue has been growing slightly by 1.97% on average over the past years.
EPS 1Y (TTM)4.14%
EPS 3Y-10.69%
EPS 5Y4.4%
EPS Q2Q%4.21%
Revenue 1Y (TTM)2.9%
Revenue growth 3Y-2.67%
Revenue growth 5Y1.97%
Sales Q2Q%4.59%

3.2 Future

  • DHR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.33% yearly.
  • DHR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.17% yearly.
EPS Next Y8.89%
EPS Next 2Y8.57%
EPS Next 3Y8.92%
EPS Next 5Y10.33%
Revenue Next Year4.39%
Revenue Next 2Y4.88%
Revenue Next 3Y5.33%
Revenue Next 5Y5.17%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DHR Yearly Revenue VS EstimatesDHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
DHR Yearly EPS VS EstimatesDHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 27.66 indicates a quite expensive valuation of DHR.
  • Based on the Price/Earnings ratio, DHR is valued a bit cheaper than 73.68% of the companies in the same industry.
  • DHR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 25.40 indicates a quite expensive valuation of DHR.
  • 75.44% of the companies in the same industry are more expensive than DHR, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. DHR is around the same levels.
Industry RankSector Rank
PE 27.66
Fwd PE 25.4
DHR Price Earnings VS Forward Price EarningsDHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • DHR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DHR is cheaper than 63.16% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DHR indicates a somewhat cheap valuation: DHR is cheaper than 77.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.97
EV/EBITDA 23.61
DHR Per share dataDHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DHR does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of DHR may justify a higher PE ratio.
PEG (NY)3.11
PEG (5Y)6.29
EPS Next 2Y8.57%
EPS Next 3Y8.92%

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.58%, DHR is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.09, DHR pays a better dividend. On top of this DHR pays more dividend than 96.49% of the companies listed in the same industry.
  • With a Dividend Yield of 0.58, DHR pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.58%

5.2 History

  • On average, the dividend of DHR grows each year by 7.08%, which is quite nice.
  • DHR has been paying a dividend for at least 10 years, so it has a reliable track record.
  • DHR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)7.08%
Div Incr Years8
Div Non Decr Years8
DHR Yearly Dividends per shareDHR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • DHR pays out 24.29% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of DHR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP24.29%
EPS Next 2Y8.57%
EPS Next 3Y8.92%
DHR Yearly Income VS Free CF VS DividendDHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
DHR Dividend Payout.DHR Dividend Payout, showing the Payout Ratio.DHR Dividend Payout.PayoutRetained Earnings

DANAHER CORP

NYSE:DHR (2/5/2026, 8:20:24 PM)

After market: 216.9 +1.15 (+0.53%)

215.75

-3.78 (-1.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-28
Earnings (Next)04-20
Inst Owners82.98%
Inst Owner Change-2%
Ins Owners10.82%
Ins Owner Change-17.55%
Market Cap152.40B
Revenue(TTM)24.57B
Net Income(TTM)3.61B
Analysts85.16
Price Target268.83 (24.6%)
Short Float %1.22%
Short Ratio2.14
Dividend
Industry RankSector Rank
Dividend Yield 0.58%
Yearly Dividend1.23
Dividend Growth(5Y)7.08%
DP24.29%
Div Incr Years8
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.65%
Min EPS beat(2)2.56%
Max EPS beat(2)8.74%
EPS beat(4)4
Avg EPS beat(4)8.26%
Min EPS beat(4)2.56%
Max EPS beat(4)13.3%
EPS beat(8)7
Avg EPS beat(8)7.31%
EPS beat(12)11
Avg EPS beat(12)6.6%
EPS beat(16)15
Avg EPS beat(16)7.62%
Revenue beat(2)0
Avg Revenue beat(2)-0.38%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)-0.23%
Revenue beat(4)2
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)1.7%
Revenue beat(8)6
Avg Revenue beat(8)1.11%
Revenue beat(12)8
Avg Revenue beat(12)-0.11%
Revenue beat(16)11
Avg Revenue beat(16)-2.81%
PT rev (1m)1.06%
PT rev (3m)2.6%
EPS NQ rev (1m)0.22%
EPS NQ rev (3m)0.67%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE 27.66
Fwd PE 25.4
P/S 6.2
P/FCF 28.97
P/OCF 23.75
P/B 2.9
P/tB N/A
EV/EBITDA 23.61
EPS(TTM)7.8
EY3.62%
EPS(NY)8.49
Fwd EY3.94%
FCF(TTM)7.45
FCFY3.45%
OCF(TTM)9.08
OCFY4.21%
SpS34.78
BVpS74.37
TBVpS-11.94
PEG (NY)3.11
PEG (5Y)6.29
Graham Number114.25
Profitability
Industry RankSector Rank
ROA 4.33%
ROE 6.88%
ROCE 6.14%
ROIC 5.19%
ROICexc 5.52%
ROICexgc 35.89%
OM 19.15%
PM (TTM) 14.71%
GM 59.17%
FCFM 21.41%
ROA(3y)4.99%
ROA(5y)6.19%
ROE(3y)7.87%
ROE(5y)10.34%
ROIC(3y)5.75%
ROIC(5y)6.56%
ROICexc(3y)6.08%
ROICexc(5y)6.96%
ROICexgc(3y)45.8%
ROICexgc(5y)53.12%
ROCE(3y)6.8%
ROCE(5y)7.77%
ROICexgc growth 3Y-17.71%
ROICexgc growth 5Y-9.63%
ROICexc growth 3Y-15.45%
ROICexc growth 5Y-0.71%
OM growth 3Y-12.28%
OM growth 5Y0.11%
PM growth 3Y-17.98%
PM growth 5Y-1.36%
GM growth 3Y-0.91%
GM growth 5Y1.09%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.5
Debt/EBITDA 2.57
Cap/Depr 47.24%
Cap/Sales 4.71%
Interest Coverage 250
Cash Conversion 89.71%
Profit Quality 145.54%
Current Ratio 1.87
Quick Ratio 1.51
Altman-Z 4.36
F-Score5
WACC10.94%
ROIC/WACC0.47
Cap/Depr(3y)56.76%
Cap/Depr(5y)56.36%
Cap/Sales(3y)5.44%
Cap/Sales(5y)5.17%
Profit Quality(3y)134.42%
Profit Quality(5y)123.93%
High Growth Momentum
Growth
EPS 1Y (TTM)4.14%
EPS 3Y-10.69%
EPS 5Y4.4%
EPS Q2Q%4.21%
EPS Next Y8.89%
EPS Next 2Y8.57%
EPS Next 3Y8.92%
EPS Next 5Y10.33%
Revenue 1Y (TTM)2.9%
Revenue growth 3Y-2.67%
Revenue growth 5Y1.97%
Sales Q2Q%4.59%
Revenue Next Year4.39%
Revenue Next 2Y4.88%
Revenue Next 3Y5.33%
Revenue Next 5Y5.17%
EBIT growth 1Y-9.68%
EBIT growth 3Y-14.62%
EBIT growth 5Y2.08%
EBIT Next Year18.19%
EBIT Next 3Y12.46%
EBIT Next 5Y11.46%
FCF growth 1Y-0.68%
FCF growth 3Y-10.62%
FCF growth 5Y-0.59%
OCF growth 1Y-4.07%
OCF growth 3Y-9.02%
OCF growth 5Y0.66%

DANAHER CORP / DHR FAQ

What is the fundamental rating for DHR stock?

ChartMill assigns a fundamental rating of 6 / 10 to DHR.


What is the valuation status for DHR stock?

ChartMill assigns a valuation rating of 4 / 10 to DANAHER CORP (DHR). This can be considered as Fairly Valued.


What is the profitability of DHR stock?

DANAHER CORP (DHR) has a profitability rating of 7 / 10.


What is the expected EPS growth for DANAHER CORP (DHR) stock?

The Earnings per Share (EPS) of DANAHER CORP (DHR) is expected to grow by 8.89% in the next year.


Is the dividend of DANAHER CORP sustainable?

The dividend rating of DANAHER CORP (DHR) is 6 / 10 and the dividend payout ratio is 24.29%.